Synergism of bacterial lipopolysaccharides and concanavalin A in the activation of thymic lymphocytes.
D000818:Animals; D001973:Bromodeoxyuridine; D003208:Concanavalin A; D003348:Cortisone; D004247:DNA / Q000096:biosynthesis; D004357:Drug Synergism; D007106:Immune Sera; D008070:Lipopolysaccharides; D008213:Lymphocyte Activation; D051379:Mice; D008806:Mice, Inbred AKR; D008808:Mice, Inbred CBA; D011135:Polysaccharides, Bacterial; D012486:Salmonella typhimurium / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D013936:Thymidine / Q000378:metabolism; D013950:Thymus Gland / Q000166:cytology; D014316:Tritium
D007106:Immune Sera; D008070:Lipopolysaccharides; D011135:Polysaccharides, Bacterial; D014316:Tritium; D003208:Concanavalin A; D004247:DNA; D001973:Bromodeoxyuridine; D003348:Cortisone; D013936:Thymidine